Identification of Potential Prognostic Biomarkers in Patients with Untreated, Advanced Pancreatic Cancer from a Phase III Trial (CALGB 80303)
- Citation:
- Cancer vol 118 (2) 571-578
- Year:
- 2012
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 1
- Parents:
- None
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Pharmas:
- Grants:
- CA33601, CA47577, CA32291, CA41287, CA7765, CA77440, CA17145, CA47559, CA45418, U10 CA031946-31, U10 CA031946-29, CA21115, CA31946
- Corr. Author:
- Authors:
- Andrew S. Roberts Michael J. Campa Elizabeth B. Gottlin Chen Jiang Kouros Owzar Hedy L. Kindler Alan P. Venook Richard M. Goldberg Eileen M. O'Reilly Edward F. Patz
- Networks:
- Study
- CALGB-80303
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- pancreatic neoplasms, prognosis, biological markers, bevacizumab, alpha 1-antichymotrypsin